Trading news releases and fundamentals, w/ biotech day trader John Welsh

This weeks guest is a little different to many of the guests I’ve had on in the past. Instead of giving very little weight to fundamentals and news releases, these two things actually form the foundation for his trading approach. In fact, he almost disregards charts altogether, and he relates the reason for this to his background in accounting and finance.

John Welsh has been a full time trader for over 10 years and he’s racked up millions of dollars in profits along the way.

His trading consists of both intraday and swing trading, and he concentrates mainly on Biotech stocks, making roughly 90% of his trades within this sector.

Now that I’ve given you the 1,000 ft view on John’s trading journey, here he is to fill in the blanks, and give us a lot more depth around his approach.

source

Leave a Reply

Your email address will not be published. Required fields are marked *